Dimension scores are derived from public data and fields; weighted into the composite. Reference only.
pohl-boskamp.de is the corporate website of Germany’s G. Pohl-Boskamp GmbH & Co. KG. Based in Hohenlockstedt, Schleswig-Holstein, the company is an independent, mid-sized, family-owned pharmaceutical business that emphasizes R&D and manufacturing in Germany. The site has a clear positioning: it presents the company’s capabilities, therapeutic areas, pharmaceutical brands, news updates, and a service portal for pharmacists.
The website mainly includes a company profile, explanations of therapeutic areas, an overview of medicines and medical products, corporate news, media contacts, and a pharmacist login service. Its coverage includes respiratory diseases, coronary heart disease and angina, tinnitus, voice/throat conditions, head lice, skin, and urology/bladder-related areas. Notably, Pohl-Boskamp does not only sell traditional medicines; it is also active in Germany’s DiGA digital health application sector, for example by promoting the Kalmeda® tinnitus therapy app and through an exclusive market partnership with the HELP chronic pain app.
The official website does not provide specific consumer-facing drug prices, nor does it offer online purchasing or checkout. Some digital therapies, such as Kalmeda®, fall under Germany’s “prescription app” model: they can be prescribed by doctors and reimbursed by Germany’s statutory health insurance system. For Chinese users, this pricing and reimbursement information has limited practical value, as it depends on Germany’s healthcare insurance and regulatory framework.
The advantages are a solid corporate background, a mature product portfolio, and an emphasis on German-based quality control. The site is updated frequently with news, making it possible to track clinical studies, policy engagement, and the company’s digital therapeutics strategy. Kalmeda® has also been recognized in reviews by Stiftung Warentest, which strengthens the credibility of its digital health products. The drawbacks are that the website is almost entirely in German, with no Chinese or international user guidance; information on purchase channels, international availability, and pricing is insufficient; and the pharmacist service portal requires registration, leaving ordinary users with limited interactive features.
This website is better suited to patients, pharmacists, doctors, pharmaceutical partners, industry researchers, and media reporters in Germany and Europe. If Chinese users simply want to purchase related medicines, the official website is not a direct transaction channel; it is more useful for understanding the brand, treatment areas, and corporate credentials.
Judging by the nature of the site, it is a standard German corporate website, with no obvious signs of requiring a proxy or enforcing regional blocking. It is expected to be directly accessible from mainland China. However, due to language, regulatory, and cross-border pharmaceutical distribution restrictions, its practical value for Chinese users is mainly as an information source rather than a channel for direct medical services or purchases.
⚠ This review is compiled from public sources and does not constitute a purchase recommendation. Verify all facts on the vendor's official site. Verify on pohl-boskamp.de official site.
pohl-boskamp.de is an Germany other provider. TG4G tracks its product information, an overall rating of 6.0/10, and a China-accessibility score of Unknown. Click "Visit Official Site" to reach pohl-boskamp.de directly.